%0 Journal Article
%T Fetal exposure to bisphenol A as a risk factor for the development of childhood asthma: an animal model study
%A Yoichi Nakajima
%A Randall M Goldblum
%A Terumi Midoro-Horiuti
%J Environmental Health
%D 2012
%I BioMed Central
%R 10.1186/1476-069x-11-8
%X Female BALB/c mice received 10 micro g/ml BPA in their drinking water from one week before pregnancy until the end of the study. Some of the pups were transferred in the first 48 h of life from their BPA-loaded mother to an unexposed mother, or vice versa. Half of the pups were sensitized with a low dose of the experimental allergen ovalbumin (OVA), the rest received PBS as an unsensitized controls. On day 22, the pups were challenged by inhalations of ovalbumin or PBS followed by quantification of eosinophils in and hyperreactivity of their airways, major indicators of experimental asthma in this classical mouse model. Hepatic expression of two isoforms of UDP-glucuronosyltransferase (Ugt) was quantified by quantitative RT-PCR at various ages.Pups exposed to BPA in utero and through breast milk, or in utero only, displayed an asthma phenotype in response to their "suboptimal" allergic sensitization, whereas, pups only exposed to BPA postnatally from breast milk, did not. The expression of Ugt2b1, an isoform related to BPA clearance in rats, was not detectable in mouse fetuses and newborn pups, but increased by day 5 and approached adult levels by day 25.Prenatal exposures that produce environmentally relevant burdens of BPA, followed by postnatal allergic sensitization and challenges, promote the development of experimental allergic asthma. Delayed expression of BPA-metabolizing enzymes may explain, at least in part, the enhanced fetal susceptibility to this common environmental contaminant.The production of the industrial chemical bisphenol A (BPA) is one of the largest in the world (approximately 2.4 billion pounds in 2007 [1]). BPA has been used for over 40 years to make hard plastic products, such as, baby bottles, food-storage containers, lining for food and beverage containers, and dental sealants. The estrogenic effects of BPA in experimental animals make it a potential endocrine disruptor [2,3]. In January 2010, the US Food and Drug Administration (FDA) cha
%K Animal model
%K Asthma
%K Bisphenol A
%K BPA
%K Environmental estrogen
%K Enzyme
%K Fetal exposure
%K Metabolism
%K Ovalbumin
%K Ugt2b1
%U http://www.ehjournal.net/content/11/1/8